![Egis Atorvastatin - Dapagliflozin](https://www.pharmacompass.com/image/flap/egis-kp-dapagliflozin-atorvastatin-desktop-headergif-44362.gif)
![Egis Atorvastatin - Dapagliflozin](https://www.pharmacompass.com/image/flap/egis-kp-dapagliflozin-atorvastatin-mobile-headergif-34900.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
Impressions: 1624
https://www.pharmacompass.com/radio-compass-blog/amgen-ends-humira-s-20-year-reign-in-us-with-amjevita-launch
Impressions: 2664
https://www.pharmacompass.com/radio-compass-blog/america-s-drug-price-hike-conundrum-in-backdrop-of-2019-medicare-part-d-data
Impressions: 4740
https://www.pharmacompass.com/radio-compass-blog/china-s-energy-crunch-threatens-pharma-supply-chains
Impressions: 69941
https://www.pharmacompass.com/radio-compass-blog/new-drug-approvals-by-fda-ema-mid-2020-recap
Impressions: 55099
https://www.pharmacompass.com/radio-compass-blog/top-drugs-and-pharmaceutical-companies-of-2019-by-revenues
Impressions: 2523
https://www.pharmacompass.com/radio-compass-blog/analyzing-over-us-90-billion-of-medicare-prescription-drug-part-d-spending-in-2016
Impressions: 3112
https://www.pharmacompass.com/radio-compass-blog/seven-of-your-facilities-are-out-of-compliance-fda-tells-wockhardt-mylan-s-epipen-sales-crash
Impressions: 7966
https://www.pharmacompass.com/radio-compass-blog/drug-costs-and-prescription-trends-in-the-united-states-analyzing-medicare-s-121-billion-spend
Impressions: 3019
https://www.pharmacompass.com/radio-compass-blog/compliance-wrap-heparin-quality-concerns-re-emerge-in-china-more-trouble-at-sun-pharma-wockhardt
Impressions: 7104
https://www.pharmacompass.com/radio-compass-blog/a-21st-century-cure-for-generics-via-the-big-data-revolution
Impressions: 3437
https://www.pharmacompass.com/radio-compass-blog/haunted-teva-s-1-2-billion-pay-for-delay-penalty-which-companies-will-get-hit-next
Impressions: 4166
https://www.pharmacompass.com/radio-compass-blog/will-data-integrity-concerns-on-clinical-trials-done-at-gvk-biosciences-go-beyond-europe
Impressions: 8841
https://www.pharmacompass.com/radio-compass-blog/the-next-generic-attack-brilinta-ticagrelor-xarelto-rivaroxaban-tradjenta-linagliptin-and
Impressions: 3160
https://www.pharmacompass.com/radio-compass-blog/dr-reddy-s-expansion-plans-for-api-production